Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bryan Huber

Co-Targeting Aurora Kinase With PD-L1 and PI3K Abrogates Immune Checkpoint Mediated Proliferation in Peripheral T-Cell Lymphoma: A Novel Therapeutic Strategy

Oncotarget

Oncology

2017

English

In-Office Diagnostic Arthroscopy for Knee and Shoulder Intra-Articular Injuries Its Potential Impact on Cost Savings in the United States

BMC Health Services Research

Health Policy

2014

English

Related publications

Direct Therapeutic Targeting of Immune Checkpoint PD-1 in Pancreatic Cancer

British Journal of Cancer

Cancer Research

Oncology

2018

English

Therapeutic Options in Peripheral T Cell Lymphoma

Journal of Hematology and Oncology

English

ARD1-mediated Aurora Kinase a Acetylation Promotes Cell Proliferation and Migration

Oncotarget

Oncology

2017

English

Phosphatidylinositol 3-Kinase-Δ (PI3K-δ) Is a Potential Therapeutic Target in Adult T-Cell Leukemia-Lymphoma

Biomarker Research

Biochemistry

Molecular Medicine

Clinical Biochemistry

2018

English

The Therapeutic Promise of Disrupting the PD-1/PD-L1 Immune Checkpoint in Cancer: Unleashing the CD8 T Cell Mediated Anti-Tumor Activity Results in Significant, Unprecedented Clinical Efficacy in Various Solid Tumors

Journal for ImmunoTherapy of Cancer

English

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

English

PD-L1-specific Helper T-Cells Exhibit Effective Antitumor Responses: New Strategy of Cancer Immunotherapy Targeting PD-L1 in Head and Neck Squamous Cell Carcinoma

Journal of Translational Medicine

English

839 Dual Targeting Autoinflammation and PD-L1/L2 Immune Checkpoint by EGCG Augments Anti-Tumor Effects in Melanoma

Journal of Investigative Dermatology

English

Crosslink Between Temozolomide and PD-L1 Immune-Checkpoint Inhibition in Glioblastoma Multiforme

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bryan Huber

Co-Targeting Aurora Kinase With PD-L1 and PI3K Abrogates Immune Checkpoint Mediated Proliferation in Peripheral T-Cell Lymphoma: A Novel Therapeutic Strategy

In-Office Diagnostic Arthroscopy for Knee and Shoulder Intra-Articular Injuries Its Potential Impact on Cost Savings in the United States

Related publications

Direct Therapeutic Targeting of Immune Checkpoint PD-1 in Pancreatic Cancer

Therapeutic Options in Peripheral T Cell Lymphoma

ARD1-mediated Aurora Kinase a Acetylation Promotes Cell Proliferation and Migration

Phosphatidylinositol 3-Kinase-Δ (PI3K-δ) Is a Potential Therapeutic Target in Adult T-Cell Leukemia-Lymphoma

The Therapeutic Promise of Disrupting the PD-1/PD-L1 Immune Checkpoint in Cancer: Unleashing the CD8 T Cell Mediated Anti-Tumor Activity Results in Significant, Unprecedented Clinical Efficacy in Various Solid Tumors

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer

PD-L1-specific Helper T-Cells Exhibit Effective Antitumor Responses: New Strategy of Cancer Immunotherapy Targeting PD-L1 in Head and Neck Squamous Cell Carcinoma

839 Dual Targeting Autoinflammation and PD-L1/L2 Immune Checkpoint by EGCG Augments Anti-Tumor Effects in Melanoma

Crosslink Between Temozolomide and PD-L1 Immune-Checkpoint Inhibition in Glioblastoma Multiforme